Search Within

Eric J Sherman

Formats
  1. Meeting Abstract (187)
  2. Journal Article (141)
  3. Review (6)
  4. Correspondence (5)
  5. Editorial (3)
  6. Research Letter (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (346)
  2. Head and Neck Service (346)
  3. Solid Tumor Oncology Division (346)
  4. Radiation Oncology, Department of (203)
  5. Surgery (171)
  6. Head and Neck Surgery (169)

More Groups

People
  1. Nancy Lee (199)
  2. Nadeem Riaz (148)
  3. David Pfister (126)
  4. Sean McBride (111)
  5. Richard Wong (109)
  6. Alan Ho (88)

More People

Years
  1. 2025 (7)
  2. 2024 (36)
  3. 2023 (24)
  4. 2022 (29)
  5. 2021 (21)
  6. 2020 (38)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (94)
  2. Journal of Clinical Oncology (85)
  3. Annals of Oncology (19)
  4. Cancer (16)
  5. Head & Neck (16)
  6. Oral Oncology (8)

More Publications

Publishers
  1. Elsevier Inc. (110)
  2. American Society of Clinical Oncology (87)
  3. Oxford University Press (27)
  4. Wiley Blackwell (26)
  5. John Wiley & Sons, Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (346)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Phase II study of lenvatinib in patients with progressive, recurrent or metastatic adenoid cystic carcinoma
    Journal Article

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Baxi, S.; Katabi, N.; Antonescu, C. R.; Ostrovnaya, I.; Haque, S. S.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature
    Review

    Beckham, T. H.; Leeman, J.; Tsai, C. J.; Riaz, N.; Sherman, E.; Singh, B.; Lee, N.; McBride, S.; Higginson, D. S.
    Head & Neck (2019)

    Fulltext@MSK | Save
  • Prolongation of tumour volume doubling time (midDT) is associated with improvement in disease-specific survival in patients with rapidly progressive radioactive iodine refractory differentiated thyroid cancer selected for molecular targeted therapy
    Journal Article

    Sabra, M. M.; Sherman, E.; Tuttle, R. M.
    Clinical Endocrinology (2019)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Katabi, N.; Ni, A.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Combination of dabrafenib (DAB) and lapatinib (LAP) for the treatment of BRAF-mutant thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fagin, J. A.; Haque, S.; Robinson, C.; Ghossein, R. A.; Chen, H. X.; Pfister, D. G.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated with LOXO-292
    Meeting Abstract

    Oxnard, G. R.; Drilon, A. E.; Shah, M. H.; Wirth, L. J.; Bauer, T. M.; Velcheti, V.; Lakhani, N. J.; Besse, B.; Park, K.; Patel, J. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Radiotherapy to demonstrate persistent overall survival benefit in locally advanced or metastatic anaplastic thyroid cancer
    Meeting Abstract

    Ma, J.; Bell, A. C.; Lok, B. H.; Leeman, J. E.; Anderson, E. S.; Riaz, N.; McBride, S. M.; Ganly, I.; Shaha, A. R.; Sherman, E. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1/2 precision medicine study of the next-generation BRAF inhibitor PLX8394
    Meeting Abstract

    Janku, F.; Vaishampayan, U. N.; Khemka, V.; Bhatty, M.; Sherman, E. J.; Tao, J.; Whisenant, J. R.; Hong, D. S.; Bui, N.; Kummar, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save